A transcriptional program associated with cell cycle regulation predominates in the anti-inflammatory effects of CX-5461 in macrophage

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• CX-5461 is a selective RNA polymerase I inhibitor with potential anti-inflammatory and immunosuppressive properties.
• The precise molecular mechanisms of CX-5461's effects on macrophage-mediated inflammation require further elucidation.

Purpose of the Study:

• To identify systemic biological processes modulated by CX-5461 in inflammatory macrophages.
• To clarify the molecular mechanisms underlying CX-5461's inhibitory effects on macrophage inflammation.

Main Methods:

• Primary peritoneal macrophages were isolated from Sprague Dawley rats and stimulated with lipopolysaccharide or interferon-γ.
• Genome-wide RNA sequencing was performed, followed by Gene Ontology and KEGG pathway enrichment analysis using R software.
• Functional annotations and enrichment analysis were conducted using ClusterProfiler.

Main Results:

• CX-5461 induced a cell cycle inhibition signature in primed macrophages, characterized by downregulated cell cycle mediators and upregulated inhibitors.
• While some inflammatory genes (e.g., IL-1β, gp91phox) were downregulated, CX-5461 did not elicit a systemic anti-inflammatory transcriptional program at the tested concentration.
• The p53 pathway was identified as a key regulator of molecular networks responsive to CX-5461 treatment.

Conclusions:

• The primary mechanism of CX-5461's inhibitory effect on macrophage-mediated inflammation involves the limitation of cell proliferation.
• CX-5461's impact on inflammation is predominantly linked to cell cycle arrest rather than a comprehensive anti-inflammatory transcriptional response.
• The p53 pathway plays a crucial role in mediating CX-5461's effects on inflammatory macrophages.